This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Arrhythmias  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We wish to raise some methodological concerns about the article by Dr Al-Khatib and colleagues.¹

Although the authors described a MEDLINE search, they did not provide a critical summary of published reports of drugs affecting the QT interval. Similarly, they did not include information from pharmacovigilance or postmarketing databases. Rather, their main table of results is based on an opinion survey whose methods and results were not presented.

Thus, we believe that several of their conclusions are unwarranted. For instance, the authors categorize sertraline's "potential . . . for causing QT prolongation" as "possible in high-risk patients." Yet there are no published data documenting that sertraline treatment is associated with QT prolongation or torsades de pointes in any high-risk patient population. Furthermore, in a double-blind, placebo-controlled clinical trial, Glassman et al² reported that sertraline was not associated with a risk of QT prolongation or torsades de pointes . . . [Full Text of this Article]

John A. Gillespie, MD; Cathryn M. Clary, MD
Pfizer Inc
New York, NY

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Medications That Prolong the QT Interval
Mori J. Krantz, Bridget A. Martell, Julia H. Arnsten, and Marc N. Gourevitch
JAMA. 2003;290(8):1025.
EXTRACT | FULL TEXT  

Medications That Prolong the QT Interval
Carol Cappuccio
JAMA. 2003;290(8):1026.
EXTRACT | FULL TEXT  

Medications That Prolong the QT Interval—Reply
Sana M. Al-Khatib, Nancy M. Allen LaPointe, Judith M. Kramer, and Robert M. Califf
JAMA. 2003;290(8):1026.
EXTRACT | FULL TEXT  

What Clinicians Should Know About the QT Interval
Sana M. Al-Khatib, Nancy M. Allen LaPointe, Judith M. Kramer, and Robert M. Califf
JAMA. 2003;289(16):2120-2127.
ABSTRACT | FULL TEXT  

Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina
Alexander H. Glassman, Christopher M. O'Connor, Robert M. Califf, Karl Swedberg, Peter Schwartz, J. Thomas Bigger, Jr, K. Ranga Rama Krishnan, Louis T. van Zyl, J. Robert Swenson, Mitchell S. Finkel, Charles Landau, Peter A. Shapiro, Carl J. Pepine, Jack Mardekian, Wilma M. Harrison, and for the Sertraline Antidepressant Heart Attack Randomized Trial Group
JAMA. 2002;288(6):701-709.
ABSTRACT | FULL TEXT